5 Stocks I'm Buying and Eyeing in a Shaky Market
It isn’t surprising that there is hesitancy after the brutal action on the DeepSeek news.
You've reached your free article limit
You've read 0 of 1 free Pro articles.
The market is off to a shaky start on Tuesday morning, but there is some rotation back into the Magnificent Seven MAGS and semiconductors after those names were pounded on Monday. The groups that did hold up on Monday are struggling Tuesday. Financials, biotech, healthcare, consumer goods, etc, are struggling and pushing breadth down to 3,950 gainers and 5,150 decliners.
The action is slowly improving, but it isn’t surprising that there is hesitancy after the brutal action in the technology sector on the DeepSeek news. However, there appears to be growing conviction that this is not a major turning point.
I’m putting a bit more money to work but am not in a big rush. I do want to add to Nvidia NVDA before its earnings report on February 26, but I’m not in a big rush. It should have a very solid report, which will be anticipated to some degree.
On Monday, I discussed how Snowflake SNOW was likely a beneficiary of cheaper AI models such as DeepSeek. The theme continues to work Tuesday, with SalesForce CRM and Meta META moving strongly. I’m adding a position in GitLab GTLB, which is another software-as-a-service play that is moving strongly.
Another name I am adding today is Upwork UPWK, which matches contract workers with employers. The stock has been trading in a base going back to November 7 and is not pushing at highs on good volume.
My biotechnology portfolio continues to act poorly, but as soon as price action improves, I’ll be adding to names such as uniQure QURE, Rocket Pharmaceuticals RCKT, and Humacyte HUMA.
We are in a stock-picking environment right now, so that is my focus
At the time of publication, Rev Shark was long NVDA, SNOW, GTLB, UPWK, QURE, RCKT and HUMA.
